JOSH J. WANG, MD, MS

JOSH J. WANG, MD, MS


- ROSS EYE INSTITUTE -

Josh J. Wang, MD, MS | Ross Eye Institute

Vision Research Center


Specialties

  • Vision Research Center

Contact

Education

Title and Department:
Associate Professor of Research
Ophthalmology and Internal Medicine


Education and Training:
M.D. Yunyang Medical College, Tongji University of Medical Sciences, Hubei, China
M.S. (Medicine-Cardiology) Sun Yat-sen University of Medical Sciences, Guangzhou, China


Clinical Fellowship (Cardiology):
The First People’s Hospital of Guangzhou, Guangzhou, China


Residency (Internal Medicine):
Yunyang Medical College-University Hospital, Tongji University of Medical Sciences, Hubei, China


Fellowships:
Medical University of South Carolina, Charleston, SC (Ophthalmology/Molecular Biology)

University of Oklahoma Health Sciences Center, Oklahoma City, OK (Medicine/Cell Biology)


Research Focus:

Collaborative clinical and epidemiological research/clinical trials, fundamental retinal processes, retinal diseases


Clinical Relevance:

Age-related macular degeneration, diabetic retinopathy, vascular diseases

Synopsis of Research

Dr. Josh J. Wang, M.D., M.S. focuses his research on studying diabetic-related vascular complications, including diabetic retinopathy, diabetic vascular disease, insulin resistance and diabetic nephropathy. In addition to addressing mechanisms, our cellular and biochemical studies are meant to develop cures for diseases that affect the retina, peripheral vessel and kidney.


  1. Diabetic retinopathy: Focusing on endoplasmic reticulum (ER) stress activation and interactions among ER stress, oxidative stress and inflammation in retina.
  2. Periphral vascular disease (PVD): Endothelial cells in the vascular system are especially vulnerable to hyperglycemic conditions. Exploring endothelial dysfunction in diabetic setting, would aid in the search for novel approaches in the prevention of diabetes vascular disease.
  3. Diabetic nephropathy: Glomerular endothelial cells and podocytes are primary sites of injury resulting in chronic kidney disease in diabetes. We investigate the function of endogenous angiogenic inhibitors in regulation of renal cells in diabetic kidney.
  4. Adipocyte and insulin resistance: Studying the function of PEDF in adipogenesis, provide pivotal information for understanding the mechanisms underlying the association of PEDF, obesity and insulin resistance.


OUR DOCTORS

  • Jamie Schaefer | Ross Eye
  • Share by: